0 التعليقات
0 المشاركات
544 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Radiopharmaceuticals Market Size, Share, Trends, Key Drivers, Growth, Challenges and Opportunity ForecastExecutive Summary Radiopharmaceuticals Market: Growth Trends and Share Breakdown The global radiopharmaceuticals market was valued at USD 16.30 billion in 2024 and is expected to reach USD 26.98 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 6.50%, primarily driven by the rising prevalence of cancer and cardiovascular diseases, along with...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Radiopharmaceuticals Market Size, Trends, Demand, Growth and Opportunity AnalysisFuture of Executive Summary Radiopharmaceuticals Market Size and Share Dynamics During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 6.50%, primarily driven by the rising prevalence of cancer and cardiovascular diseases, along with increasing adoption of targeted diagnostic and therapeutic procedures. Radiopharmaceuticals Market research report is a sure...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Radiopharmaceuticals Market Statistics, Trends and Forecast Analysis 2026–2035" According to the latest report published by Data Bridge Market Research, the Radiopharmaceuticals Market The global radiopharmaceuticals market was valued at USD 16.30 billion in 2024 and is expected to reach USD 26.98 billion by 2032, at a CAGR of 6.50% during the forecast period. The universal Radiopharmaceuticals Market research report is a complete overview of the market...0 التعليقات 0 المشاركات 6 مشاهدة 0 معاينة
-
Europe Radiopharmaceuticals Market Industry Opportunity Landscape and Growth Analysis" According to the latest report published by Data Bridge Market Research, the Europe Radiopharmaceuticals Market The Europe radiopharmaceuticals market size was valued at USD 2.47 billion in 2024 and is expected to reach USD 3.91 billion by 2032, at a CAGR of 5.9% during the forecast period. The large scale Europe Radiopharmaceuticals Market report is produced with the several...0 التعليقات 0 المشاركات 5 مشاهدة 0 معاينة
-
Oncology Radiopharmaceuticals Market Size to Reach USD 89.7 Billion by 2032“According to a new report published by Introspective Market Research, Oncology Radiopharmaceuticals Market by Type, Application, and End User, The Global Oncology Radiopharmaceuticals Market Size Was Valued at USD 3.5 Billion in 2023 and is Projected to Reach USD 89.7 Billion by 2032, Growing at a CAGR of 43.4% From 2024–2032.” The oncology radiopharmaceuticals market...0 التعليقات 0 المشاركات 789 مشاهدة 0 معاينة
-
Radiopharmaceuticals Market Size, Demand, Growth and Competitive AnalysisExecutive Summary Radiopharmaceuticals Market Size and Share: Global Industry Snapshot During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 6.50%, primarily driven by the rising prevalence of cancer and cardiovascular diseases, along with increasing adoption of targeted diagnostic and therapeutic procedures. For an actionable market insight and lucrative...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Radiopharmaceuticals Market: Unlocking Precision in Nuclear MedicineThe global radiopharmaceuticals market was valued at USD 16.30 billion in 2024 and is expected to reach USD 26.98 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 6.50%, primarily driven by the rising prevalence of cancer and cardiovascular diseases, along with increasing adoption of targeted diagnostic and therapeutic procedures...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Radiopharmaceuticals on the Rise: Market Outlook and Future Insights Industry Overview and Forecast to 2032The global radiopharmaceuticals market was valued at USD 16.30 billion in 2024 and is expected to reach USD 26.98 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 6.50%, primarily driven by the rising prevalence of cancer and cardiovascular diseases, along with increasing adoption of targeted diagnostic and therapeutic procedures...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek